Maryland bills · 2026 Regular Session
Maryland HB 484
Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Watson (Democratic)
- Moreno (Democratic)
- Hill (Democratic)
- Guzzone (Democratic)
- Ebersole (Democratic)
- Cullison (Democratic)
- Charkoudian (Democratic)
- Addison (Democratic)
- Terrasa (Democratic)
- Feldmark (Democratic)
- Ziegler (Democratic)
Summary
No official summary is available for this bill.
Latest action(Jan 23, 2026): Hearing 2/12 at 1:00 p.m.
Text versions
- First - Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 23, 2026 · House
Hearing 2/12 at 1:00 p.m. - Jan 23, 2026 · House
First Reading Ways and Means